Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
type: MedicalStudy
description: Reduced Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Randomised, Multi-Center, Phase III Study
status: ENROLLING_BY_INVITATION
study design: INTERVENTIONAL
phase: PHASE3
start date: 2023-02-15
end date: 2025-12-30
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05674539
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
study subject: Acute Myeloid Leukemia, Adult
study subject: Myelodysplastic Syndrome(MDS)
study subject: Allogeneic Hematopoietic Stem Cell Transplantation
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: ENROLLING_BY_INVITATION
keywords: Acute Myeloid Leukemia, Adult
keywords: Myelodysplastic Syndrome(MDS)
keywords: Allogeneic Hematopoietic Stem Cell Transplantation

AI Analytics
type: Organization